Loading...
Header Logo
Keywords
Last Name
Institution

Gerardo Gonzalez-Haddad MD

TitleAssociate Professor
InstitutionUniversity of Massachusetts Medical School
DepartmentPsychiatry
AddressUniversity of Massachusetts Medical School
365 Plantation Street, Biotech One
Worcester MA 01605
Phone508-856-0480
vCardDownload vCard
    Other Positions
    InstitutionUMMS - School of Medicine
    DepartmentPsychiatry


    Collapse Biography 
    Collapse education and training
    Colegio Mayor de Nuestra Senora del Rosario, Bogota, , ColombiaMD

    Collapse Overview 
    Collapse overview

    Academic Background

    1978, BC, Colegio San Viator, Bogotá, Colombia

    1984, MD, Colegio Mayor de Nuestra Señora del Rosario Bogotá, Colombia

    1989, Psychiatry Residency, Colegio Mayor de Nuestra Señora del Rosario, Bogotá, Colombia

    1992, DAB, Addiction Behaviour, University of London, Institute of Psychiatry, London, UK

    1996, Psychiatry Residency, Yale University, New Haven, CT

    2001, Addiction Psychiatry Fellow, Yale University, New Haven, CT

    Director, Addiction Psychopharmacology Research
    Director, Addiction Psychiatry Fellowship Program

    Director, Addiction & Comorbidity Treatment Service (ACTS)

    Gerardo Gonzalez

    Research Interests

    The clinical research that our group has been conducting has focused on the neurobiology and pharmacotherapy for cocaine and opioid dependence. The series of studies have evaluated the extent that enhancing GABA neurotransmission may have in modifying cocaine and opiate taking behavior. In addition, we are interested in understanding whether modulation of glutamate neurotransmission by an uncompetitive NMDA receptor antagonist during opioid agonist treatment may improve treatment outcomes and reduce early relapse in young adults with opiate dependence. The study is expected to provide valuable information whether co-administration of memantine to buprenorphine treatment will modify components of opioid dependence, and therefore become a time-limited alternative to the long term agonist maintenance treatment for young opioid dependent adults.




    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. González G, Giraldo LF, DiGirolamo G, Rey CF, Correa LE, Cano AM, Romero-González M. Facing the Growing Heroin Problem in Colombia: The New Methadone-assisted Treatment Programs. Rev Colomb Psiquiatr. 2019 Apr - Jun; 48(2):96-104. PMID: 30981333.
      View in: PubMed
    2. Gonzalez G, DiGirolamo G, Romero-Gonzalez M, Smelson D, Ziedonis D, Kolodziej M. Memantine improves buprenorphine/naloxone treatment for opioid dependent young adults. Drug Alcohol Depend. 2015 Nov 01; 156:243-53. PMID: 26454835.
      View in: PubMed
    3. Oliveto A, Poling J, Mancino MJ, Feldman Z, Cubells JF, Pruzinsky R, Gonsai K, Cargile C, Sofuoglu M, Chopra MP, Gonzalez-Haddad G, Carroll KM, Kosten TR. Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients. Drug Alcohol Depend. 2011 Jan 15; 113(2-3):184-91. PMID: 20828943.
      View in: PubMed
    For assistance with using Profiles, please refer to the online tutorials or contact UMMS Help Desk or call 508-856-8643.
    Gonzalez-Haddad's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _